Narrow search
Showing 1 - 10 of 25
Cover Image
Insurance Design and Pharmaceutical Innovation
Agha, Leila - 2020
This paper studies how insurance coverage policies affect incentives for pharmaceutical innovation. In the United …
Persistent link: https://www.econbiz.de/10012481418
Cover Image
Expected Profits and The Scientific Novelty of Innovation
Dranove, David - 2020
Innovation policy involves trading off monopoly output and pricing in the short run in exchange for incentives for …
Persistent link: https://www.econbiz.de/10012481677
Cover Image
Organizing Crisis Innovation : Lessons from World War II
Gross, Daniel P. - 2020
World War II innovation model in other crises. In this essay we describe exactly how it worked. We do so first through a … general overview of how OSRD approached several questions that may confront any crisis innovation effort: priority setting … innovation policy different, how crisis innovation policy approaches may vary, and the limits to generalizing from World War II …
Persistent link: https://www.econbiz.de/10012482128
Cover Image
Price Indices and the Value of Innovation with Heterogenous Patients
Lucarelli, Claudio; Nicholson, Sean; Tilipman, Nicholas - National Bureau of Economic Research - 2021
justify high prices for the population as a whole, innovation improves the welfare of sicker, late-stage cancer patients. A …
Persistent link: https://www.econbiz.de/10012482551
Cover Image
Technology Diffusion and Productivity Growth in Health Care
Skinner, Jonathan - 2009
Inefficiency in the U.S. health care system has often been characterized as "flat of the curve" spending providing little or no incremental value. In this paper, we draw on macroeconomic models of diffusion and productivity to better explain the empirical patterns of outcome improvements in...
Persistent link: https://www.econbiz.de/10012463783
Cover Image
Cost-Offsets of New Medications for Treatment of Schizophrenia
Frank, Richard G. - 2006
Broad claims are frequently made that new medications will offset all or part of their costs by reducing other areas of Medicaid spending. In this paper we examine the net impact on spending for new drugs used to treat schizophrenia. We extend research in this area by taking a new approach to...
Persistent link: https://www.econbiz.de/10012466018
Cover Image
The Impact of Price Regulation on the Launch Delay of New Drugs - Evidence from Twenty-Five Major Markets in the 1990s
Danzon, Patricia Munch - 2003
This study analyzes the effect of pharmaceutical price regulation on delays in new drug launches. Because low price in one market may 'spill-over' to others, though parallel trade and external referencing, manufacturers may rationally prefer longer delay or non-launch to accepting a low price....
Persistent link: https://www.econbiz.de/10012468823
Cover Image
The impact of new drug launches on longevity : evidence from longitudinal disease-level data from 52 countries, 1982-2001
Lichtenberg, Frank R. - 2003
We perform an econometric analysis of the effect of new drug launches on longevity, using data from the IMS Health Drug Launches database and the WHO Mortality Database. Our data cover virtually all of the diseases borne by people in 52 countries during the period 1982-2001, and enable us to...
Persistent link: https://www.econbiz.de/10012468944
Cover Image
"Napsterizing" Pharmaceuticals : Access, Innovation, and Consumer Welfare
Hughes, James W. - 2002
, future consumers would be harmed at a rate of three dollars in present value terms from reduced future innovation. We obtain …
Persistent link: https://www.econbiz.de/10012469480